- Home
- PKE vs RCKT Comparison
PKE vs RCKT Comparison
Compare PKE & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- RCKT
- Stock Information
- Founded
- PKE 1954
- RCKT 1999
- Country
- PKE United States
- RCKT United States
- Employees
- PKE N/A
- RCKT N/A
- Industry
- PKE Military/Government/Technical
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- RCKT Health Care
- Exchange
- PKE Nasdaq
- RCKT Nasdaq
- Market Cap
- PKE 352.8M
- RCKT 328.6M
- IPO Year
- PKE N/A
- RCKT N/A
- Fundamental
- Price
- PKE $18.66
- RCKT $3.28
- Analyst Decision
- PKE
- RCKT Buy
- Analyst Count
- PKE 0
- RCKT 13
- Target Price
- PKE N/A
- RCKT $12.96
- AVG Volume (30 Days)
- PKE 115.8K
- RCKT 6.0M
- Earning Date
- PKE 10-14-2025
- RCKT 08-07-2025
- Dividend Yield
- PKE 2.67%
- RCKT N/A
- EPS Growth
- PKE 4.18
- RCKT N/A
- EPS
- PKE 0.34
- RCKT N/A
- Revenue
- PKE $63,456,000.00
- RCKT N/A
- Revenue This Year
- PKE N/A
- RCKT N/A
- Revenue Next Year
- PKE N/A
- RCKT $108.43
- P/E Ratio
- PKE $55.09
- RCKT N/A
- Revenue Growth
- PKE 16.60
- RCKT N/A
- 52 Week Low
- PKE $11.97
- RCKT $2.19
- 52 Week High
- PKE $20.73
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- PKE 62.12
- RCKT 51.17
- Support Level
- PKE $18.81
- RCKT $2.88
- Resistance Level
- PKE $19.54
- RCKT $3.74
- Average True Range (ATR)
- PKE 0.59
- RCKT 0.27
- MACD
- PKE 0.02
- RCKT 0.02
- Stochastic Oscillator
- PKE 77.04
- RCKT 35.43
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.